The stock is in a pronounced downtrend, evidenced by a 1-year price change of -20.78% and trading near the bottom of its 52-week range, with the current price of $95.8 sitting just 13.7% above the 52-week low of $84.7. This positioning near the lows suggests the market is pricing in significant fundamental concerns, though it may also attract value-oriented investors seeking a potential bottom. Recent momentum shows a slight short-term bounce, with a 1-month gain of 3.49%, but this is overshadowed by persistent weakness, as the stock is down 9.75% over the last three months, indicating the longer-term downtrend remains firmly intact despite any temporary rallies. Key technical support is clearly defined at the 52-week low of $84.7, while resistance looms far above at the 52-week high of $132.03; a sustained breakdown below support would signal a new leg down, while the stock's low beta of 0.545 indicates it has been significantly less volatile than the broader market, which may provide some relative stability but has not prevented deep underperformance, as shown by a staggering -45.77 relative strength versus the S&P 500 over the past year.

Revenue growth is stagnant and slightly negative, with the most recent quarterly revenue of $1.673 billion representing a year-over-year decline of -0.77%, and the sequential trend from the prior quarter's $1.429 billion shows improvement but remains below levels from a year ago, indicating the company is struggling to regain top-line momentum. Profitability is present but pressured, with net income of $157 million and a gross margin of 43.16% for the latest quarter; however, gross margin has been volatile, dipping from 46.33% in the quarter ending June 2025, suggesting ongoing cost inflation or pricing challenges, though the net margin of 9.38% shows the company remains profitable. The balance sheet carries significant financial risk, highlighted by an extremely high debt-to-equity ratio of 8.97, which elevates leverage concerns, but this is partially offset by solid free cash flow generation, with TTM free cash flow of $778 million providing internal funding capacity, and a return on equity of 2.52% indicating very modest returns on shareholder capital.